Cell Robotics International Announces Second Quarter Results.ALBUQUERQUE, N.M.--(BW HealthWire)--Aug. 21, 1997--Cell Robotics International Inc. (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). :CRII CRII Cooperative Research in Information Infrastructure CRII Customer Returns Improvement Initiative ) today reported a net loss for the second quarter ended June 30, 1997 of $619,001 or 12 cents per share Cents per share The amount of a mutual fund's dividend or capital gains distributions that a shareholder will receive for each share owned. on revenues of $278,325 compared to a second quarter loss last year of $307,327 or 8 cents per share on revenues of $335,306. For the six months ended June 30, 1997, the Company reported a net loss of $1,106,440 or 22 cents per share on revenues of $534,843 compared to a net loss of $657,941 or 17 cents per share on revenues of $463,120. Revenues resulted entirely from product sales of laser instruments into research lab markets, and do not reflect any sales of medical products for which the company only recently received FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. marketing clearance. The company anticipates significant contribution to revenues in the near future from the erbium erbium (ûr`bēəm) [from Ytterby, a town in Sweden], metallic chemical element; symbol Er; at. no. 68; at. wt. 167.26; m.p. 1,529°C;; b.p. 2,863°C;; sp. gr. 9.05 at 25°C;; valence +3. :YAG YAG n. A hard synthetic yttrium aluminum garnet used in laser technology and as a gemstone. [y(ttrium) + a(luminum) + g(arnet)1.] dermatology laser and the Lasette(TM) laser finger perforator per·fo·rate v. per·fo·rat·ed, per·fo·rat·ing, per·fo·rates v.tr. 1. To pierce, punch, or bore a hole or holes in; penetrate. 2. as a result of the above mentioned clearances. Cell Robotics International Inc. develops, manufactures and markets several proprietary medical and research laser devices and associated products with application niches in large markets. In addition to the currently marketed Cell Robotics Workstation, devices under development include the Lasette laser finger perforator for sampling of blood for glucose measurements, an erbium:YAG dermatology laser, and an In Vitro Fertilization in vitro fertilization (vē`trō, vĭ`trō), technique for conception of a human embryo outside the mother's body. Several ova, or eggs, are removed from the mother's body and placed in special laboratory culture dishes (Petri dishes); Workstation targeted at improving human fertility success rates. Additional information is available on the Cell Robotics Web Site at http://www.cellrobotics.com/cell, by e-mail at crii@cellrobotics.com, or by telephone at 505/343-1131. Except for the historical information contained herein, the statements made in this release constitute forward-looking statements that involve certain risks and uncertainties. Certain factors may cause actual results to differ materially form those contained in the forward looking statements; including the volume of sales of instruments by the company and the ability of the Company to successfully manage its various contracts and the other factors detailed from time to time in the company's reports on file with the Securities and Exchange Commission. -0-
Cell Robotics International
Statements of Operations
(Unaudited)
Three Months Ended Six Months Ended
June 30, June 30, June 30, June 30,
1997 1996 1997 1996
Total revenues $ 278,325 $ 335,306 $ 534,843 $ 463,120
Net loss $(619,001) $(307,327) $(1,106,440) $ (657,941)
=========== =========== =========== ===========
Net loss
per common share (0.12) (0.08) (0.22) (0.17)
Weighted average
shares
outstanding 5,013,414 3,843,414 5,009,105 3,838,318
CONTACT: Cell Robotics International Inc. Craig Rogers Craig Rogers is a Gaelic football player from Laois in Ireland. He can play in both attack and defence and in 2003 was captain of the Laois team that won the All-Ireland Minor Football Championship title for the first time since 1997. , 719/590-1793 crii@cellrobotics.com or Richmont Consulting International Edda Brown/Sean Collins, 213/658-8088 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion